From field to pharmacopoeia: the health opportunity in Ireland's new bioeconomy strategy
JP Prendergast is co-founder and chief executive of Epitheal, and a co-author of the 2022 willow study discussed in this article.
The future of skin recovery
JP Prendergast is co-founder and chief executive of Epitheal, and a co-author of the 2022 willow study discussed in this article.
Australian pharmacists are being trained to close wounds. Irish and English ones have no pathway for them
How Epitheal is advancing with modern tools and technology, inside a governed framework that meets GDPR and EU AI Act standards, with the wider team fully equipped to …
Ireland's most cited wound care cost figure describes 2013 spending and rests on UK data. What the estimate actually says, and what a registry would change.
Formulation readiness, evidence, claims, and regulatory requirements, brought together before a product moves forward.